In the last trading session, 3.42 million shares of the ATAI Life Sciences N.V (NASDAQ:ATAI) were traded, and its beta was 1.35. Most recently the company’s share price was $2.21, and it changed around $0.15 or 7.28% from the last close, which brings the market valuation of the company to $442.75M. ATAI currently trades at a discount to its 52-week high of $2.57, offering almost -16.29% off that amount. The share price’s 52-week low was $1.03, which indicates that the current value has risen by an impressive 53.39% since then.
ATAI Life Sciences N.V stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended ATAI as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
ATAI Life Sciences N.V (NASDAQ:ATAI) trade information
Instantly ATAI has showed a green trend with a performance of 7.28% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.27 on recent trading dayincreased the stock’s daily price by 2.64%. The company’s shares are currently up 66.17% year-to-date, but still up 20.11% over the last five days. On the other hand, ATAI Life Sciences N.V (NASDAQ:ATAI) is 51.37% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 55.8% from its current value. Analyst projections state that ATAI is forecast to be at a low of $5 and a high of $5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 18.62%. ATAI Life Sciences N.V earnings are expected to increase by 39.13% in 2025, but the outlook is positive 29.20% per year for the next five years.
ATAI Dividends
ATAI Life Sciences N.V’s next quarterly earnings report is expected to be released in June.
MORGAN STANLEY, with 1.6952% or 2.72 million shares worth $3.62 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio and AdvisorShares Trust-AdvisorShares Psychedelics ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 511.99 shares worth $1.13 million, making up 0.26% of all outstanding shares. On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF held roughly 415.76 shares worth around $0.92 million, which represents about 0.21% of the total shares outstanding.
